Corrigendum to "A multicenter retrospective study of calcineurin inhibitors in nephrotic syndrome secondary to podocyte gene variants." Kidney Int. 2023;103:962-972.

MLA

Malakasioti, Georgia, et al. “Corrigendum to ‘A Multicenter Retrospective Study of Calcineurin Inhibitors in Nephrotic Syndrome Secondary to Podocyte Gene Variants.’ Kidney Int. 2023;103:962-972.” Kidney International, vol. 105, no. 1, Jan. 2024, pp. 213–14. EBSCOhost, https://doi.org/10.1016/j.kint.2023.10.006.

APA

Malakasioti, G., Iancu, D., Milovanova, A., Tsygin, A., Horinouchi, T., Nagano, C., Nozu, K., Kamei, K., Fujinaga, S., Iijima, K., Kang, H. G., Sinha, R., Basu, B., Morello, W., Montini, G., Waters, A., Boyer, O., Yıldırım, Z. Y., Yel, S., … Tullus, K. (2024). Corrigendum to “A multicenter retrospective study of calcineurin inhibitors in nephrotic syndrome secondary to podocyte gene variants.” Kidney Int. 2023;103:962-972. Kidney International, 105(1), 213–214. https://doi.org/10.1016/j.kint.2023.10.006

Chicago

Malakasioti, Georgia, Daniela Iancu, Anastasiia Milovanova, Alexey Tsygin, Tomoko Horinouchi, China Nagano, Kandai Nozu, et al. 2024. “Corrigendum to ‘A Multicenter Retrospective Study of Calcineurin Inhibitors in Nephrotic Syndrome Secondary to Podocyte Gene Variants.’ Kidney Int. 2023;103:962-972.” Kidney International 105 (1): 213–14. doi:10.1016/j.kint.2023.10.006.